Literature DB >> 17344906

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

M Golzio1, L Mazzolini, A Ledoux, A Paganin, M Izard, L Hellaudais, A Bieth, M J Pillaire, C Cazaux, J S Hoffmann, B Couderc, J Teissié.   

Abstract

RNA interference (RNAi)-mediated gene silencing approaches appear very promising for therapies based on the targeted inhibition of disease-relevant genes. The major hurdle to the therapeutic development of RNAi strategies remains, however, the efficient delivery of the RNAi-inducing molecules, the short interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs), to the target tissue. With respect to cancer treatment the development of efficient delivery methods into solid tumors appears as a critical issue. However, very few studies have addressed this problem. In this study we have investigated the contribution of electrically mediated delivery of siRNA into murine tumors stably expressing an enhanced green fluorescent protein (EGFP) target reporter gene. The silencing of EGFP gene expression was quantified over time by fluorescence imaging in the living animal. Our study indicates that electric field can be used as an efficient method for siRNA delivery and associated gene silencing into cells of solid tumors in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344906     DOI: 10.1038/sj.gt.3302920

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  24 in total

1.  Kinetics of transmembrane transport of small molecules into electropermeabilized cells.

Authors:  Gorazd Pucihar; Tadej Kotnik; Damijan Miklavcic; Justin Teissié
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

Review 2.  Physical methods of nucleic acid transfer: general concepts and applications.

Authors:  Julien Villemejane; Lluis M Mir
Journal:  Br J Pharmacol       Date:  2009-01-21       Impact factor: 8.739

3.  A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells.

Authors:  Laurence Crombez; Gudrun Aldrian-Herrada; Karidia Konate; Quan N Nguyen; Gary K McMaster; Robert Brasseur; Frederic Heitz; Gilles Divita
Journal:  Mol Ther       Date:  2008-10-28       Impact factor: 11.454

4.  In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.

Authors:  Joëlle Riond; Stéphane Rodriguez; Marie-Laure Nicolau; Talal al Saati; Jean Edouard Gairin
Journal:  Cancer Immun       Date:  2009-11-02

5.  Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells.

Authors:  A Paganin-Gioanni; E Bellard; J M Escoffre; M P Rols; J Teissié; M Golzio
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 6.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

Review 7.  In vivo imaging of RNA interference.

Authors:  Hao Hong; Yin Zhang; Weibo Cai
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

8.  Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Authors:  Michiro Susa; Arun K Iyer; Keinosuke Ryu; Edwin Choy; Francis J Hornicek; Henry Mankin; Lara Milane; Mansoor M Amiji; Zhenfeng Duan
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

Review 9.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

10.  Tracking in vitro and in vivo siRNA electrotransfer in tumor cells.

Authors:  Aurelie Paganin-Gioanni; Elisabeth Bellard; Bettina Couderc; Justin Teissié; Muriel Golzio
Journal:  J RNAi Gene Silencing       Date:  2008-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.